Jo is responsible for developing and leading the Foundation’s Healthy Lives strategy to address the wider social and commercial determinants of health. Joining the Foundation in November 2007, Jo initially led the development of the Foundation’s influential portfolio of work in patient safety and person-centred care.   Jo has worked in health care at local and national level for 25 years, including 10 years at the Department of Health. As Head of NHS Performance, she oversaw the implementation of the policy agenda set out in the NHS Plan. At the NHS Modernisation Agency, Jo led an international quality improvement initiative – Pursuing Perfection. Before joining the Foundation, Jo was the Director for the Calderdale and Kirklees Integrated Service Strategy where she led a major service reconfiguration programme to deliver improvements in quality, safety and patient experience. Between June 2013 and March 2017, Jo served as a non-executive director of Salford Royal NHS Foundation Trust.

Ian started his career in the NHS as a Biomedical Scientist and later worked as a Research Scientist in coagulation disorders before moving into NHS Leadership in the early 1990’s. He has held a variety of NHS general management posts including over 11 years as Chief Executive of acute hospital Trusts, followed by three years as the Chief Executive of a healthcare commissioning organisation prior to being appointed Chief Executive of the NHS in the West Midlands in 2009. In 2012, Ian was appointed Chief Executive of Health Education England (HEE). Ian has a particular interest in the development of leadership skills in clinical staff and is an Honorary Professor of Healthcare Leadership in the Medical School at Lancaster University. In 2003 Ian was awarded the OBE for services to the NHS and in 2010 Ian was made an honorary Fellow of the Royal College of General Practitioners. Ian has a special interest in sports medicine an area in which he hold an MSC.  Ian became a board member of Sport England in 2016. Outside work, Ian is a qualified level 3 swimming coach, working closely with young people to develop their swimming abilities, a keen snow skier and enjoys sailing, walking and watching rugby union.

Tara Donnelly is the interim Chief Digital Officer at NHSX.  NHSX has responsibility for technology, digital and data policy which has historically been split across lots of organisations and teams, and will deliver the Health Secretary’s Tech Vision, building on the NHS Long Term Plan with the objective to speed up the digital transformation of the NHS and social care. As Chief Digital Officer, Tara leads the strategy for citizen facing digital services to ensure people are empowered to manage their health care using digital services which meet their needs, target prevention and offer a personalised experience.  She is SRO for the Empower the Person (EtP) pillar, part the NHS’ Digital Transformation Portfolio.  This is one of the most ambitious digital healthcare transformation portfolios in the world.  The EtP pillar includes flagship programmes: the NHS website (nhs.uk), the NHS App, NHS login (verification of citizen’s identity), NHS Apps Library, Personal Health Records and Digital Standards, Digital Child Health, Digital Maternity, Widening Digital Participation, GP online services, and ensuring access to Wi-Fi across the NHS estate.   More information can be found at www.nhs.uk/transformation. Tara has an extensive background in leadership roles within the NHS and the voluntary and community sector.  She has a long-term passion for improvement and the potential of digital in healthcare.  She has spent the past 18 years at board level including at University College London Hospitals NHS Foundation Trust, as a non-executive director at Macmillan Cancer Support, as Chief Executive at the West Middlesex University Hospital and as Deputy Chief Executive and Director of Operations at the Whittington Hospital.  She has worked in the NHS for 30 years with her first role being as a Ward Housekeeper when she was 18. Tara is on secondment from her role as Chief Executive of the Health Innovation Network, which exists to speed up the best in health and care across south London as its academic health science network, or AHSN.  She has led the Health Innovation Network for over three years and is also a non-executive director at the Nuffield Trust.

Professor Andrew Goddard is the president of the RCP, and a consultant physician and gastroenterologist at Royal Derby Hospital. After gaining an MD from Cambridge University, Professor Goddard trained in Nottingham and was appointed as a consultant physician and gastroenterologist in Derby in 2001. He was director of the RCP’s Medical Workforce Unit for 5 years until being appointed RCP registrar in 2014. In this role, he oversaw professional and clinical affairs, both in the UK and internationally. His main policy areas were workforce, healthcare funding, the future of general medicine, the medical registrar and ‘keeping medicine brilliant’. In 2018 he was elected the 121st RCP president, the youngest for 400 years and first from the East Midlands. His priorities for his term are ‘workforce, wellbeing and worldwide’ and these will feature strongly in the RCP strategy for the next 5 years.

Dame Anne Johnson is  Professor of Infectious Disease Epidemiology at University College London and Chair of the Population and Lifelong health domain. After training in medicine in Cambridge and Newcastle Universities, she specialised in Epidemiology and Public Health. Her career has focussed on research into the epidemiology and prevention of HIV and sexually transmitted infections as well as other infections such as influenza, Ebola, and antimicrobial resistance. She co-directed the Medical Research Council, UK Centre for Co-ordinating Epidemiological Studies of HIV from 1985 until 1999 undertaking a range epidemiological studies and trials. She was principal investigator on the 3 decennial National Surveys of Sexual Attitudes and Lifestyles (Natsal).  She is an investigator on the UK I-sense programme, studying point-of-care diagnostics and digital pathways for infectious disease detection. She co-founded UCL’s Institute for Global Health and has advised many national and international science organisation. She Chaired the UK Academy of Medical Sciences (AMS) Working Group on Improving the Health of the Public by 2040.  She is a former member of the DEFRA Adaptation Sub-Committee of the Committee on Climate Change and a former Governor of the Wellcome Trust.  She  chairs the UK  Committee for  Strategic Coordination of Health  of the Public Research (SCHOPR) and is  Vice-President International of the AMS.  She was awarded the Alwyn Smith Prize by the Faculty of Public Health in 2016 and the Andrea Stampar medal in 2017 by ASPHER for her contributions to Public health research.

Professor Dame Donna Kinnair, DBE, RGN, HV, LLB, MA, CMI is the Chief Executive and General Secretary of the Royal College of Nursing. The Royal College of Nursing (RCN) is the voice of nursing across the UK. The RCN promotes patient and nursing interests on a wide range of issues by working closely with the Government, the UK parliaments and other national and European political institutions, trade unions, professional bodies and voluntary organisations. Working with the RCN Council and the Executive Team Donna is responsible for delivering the RCN’s strategic and operational plans.  Donna joined the RCN as Head of Nursing in 2015, she was then promoted and joined the RCN Executive Team to Director of Nursing, Policy and Practice in 2016, where her key role is to work with UK-wide RCN staff to drive and implement the future RCN professional nursing, policy and practice strategy. Prior to joining the RCN Donna held various roles including Clinical Director of Emergency Medicine; Executive Director of Nursing and Director of Commissioning.  Donna advised the PM’s Commission on the future of Nursing and Midwifery in 2010 and served as nurse/child health assessor to the Victoria Climbié Inquiry.

Professor of Epidemiology at University College London, and President of the World Medical Association.  He is the author of The Health Gap: the challenge of an unequal world (2015) and Status Syndrome: how your place on the social gradient directly affects your health (2004).  Professor Marmot held the Harvard Lown Professorship for 2014-2017 and is the recipient of the  Prince Mahidol Award for Public Health 2015. He has been awarded honorary doctorates from 16 universities. Marmot has led research groups on health inequalities for 40 years.  He was Chair of the Commission on Social Determinants of Health (CSDH), which was set up by the World Health Organization in 2005, and produced the report entitled: ‘Closing the Gap in a Generation’ in August 2008.  At the request of the British Government, he conducted the Strategic Review of Health Inequalities in England post 2010, which published its report ‘Fair Society, Healthy Lives’ in February 2010. This was followed by the European Review of Social Determinants of Health and the Health Divide, for WHO Euro n 2014.  He chaired the Breast Screening Review for the NHS National Cancer Action Team and was a member of The Lancet-University of Oslo Commission on Global Governance for Health.  He set up the Whitehall II Studies of British Civil Servants, investigating explanations for the striking inverse social gradient in morbidity and mortality. He leads the English Longitudinal Study of Ageing (ELSA) and is engaged in several international research efforts on the social determinants of health.  He served as President of the British Medical Association (BMA) in 2010-2011, and is President of the British Lung Foundation.  He is an Honorary Fellow of the American College of Epidemiology, a Fellow of the Academy of Medical Sciences, an Honorary Fellow of the British Academy, and an Honorary Fellow of the Faculty of Public Health of the Royal College of Physicians.  He was a member of the Royal Commission on Environmental Pollution for six years and in 2000 he was knighted by Her Majesty The Queen, for services to epidemiology and the understanding of health inequalities

Munir is currently David Weatherall Chair in Medicine at the University of Liverpool, and a Consultant Physician at the Royal Liverpool University Hospital. He also holds the only NHS Chair of Pharmacogenetics in the UK, and is Director of the M.R.C. Centre for Drug Safety Sciences, and Director of the Wolfson Centre for Personalised Medicine. He was awarded a Knights Bachelor in the Queen’s Birthday Honours list in 2015. He is currently President Elect of British Pharmacological Society and an inaugural NIHR Senior Investigator, and Fellow of the Academy of Medical Sciences in the UK. He is a Commissioner on Human Medicines. He is also a member of the MRC Governing Council and has also recently been appointed as a non-executive director of NHS England. His research focuses on personalised medicine in order to optimise drug efficacy and minimise toxicity, move discoveries from the lab to the clinic, and from clinic to application.

Samantha Roberts has recently been appointed as Chief Executive of the Accelerated Access Collaborative, the national umbrella organisation for health innovation, hosted in NHS England and NHS Improvement. She originally trained as a doctor and practiced medicine in South Africa, the UK, and Australia before undertaking an MBA and joining McKinsey and Company,  where she worked in a wide range of industries before specialising in healthcare. After McKinsey she moved into the NHS as a senior manager at a large teaching hospital in London (UCLH) and a director in an Academic Health Sciences Centre and Network (UCLPartners). Before taking on the role of Director of Innovation, Research and Life Sciences at NHS England and NHS Improvement last year. Over the last five years she has become involved in research, working with health economic models to inform evidence-based policy, initially at the London School of Economics before moving to the University of Oxford to undertake a DPhil (PhD).

Professor Chris Whitty is England’s Chief Medical Officer (CMO) and the UK Government’s Chief Medical Adviser. Chris is also the Chief Scientific Adviser (CSA) for the Department of Health and Social Care (DHSC) with overall responsibility for the department’s research and development, including the National Institute for Health Research (NIHR). Chris is a practicing NHS Consultant Physician at University College London Hospitals (UCLH) and the Hospital for Tropical Diseases, and Gresham Professor of Physic at Gresham College. Chris is an epidemiologist and has undertaken research in the UK, Africa and Asia. He was Professor of Public and International Health at the London School of Hygiene & Tropical Medicine (LSHTM) before becoming CMO. Previously Chris was the interim Government Chief Scientific Adviser 2017 to 2018 and prior to that the Chief Scientific Adviser at the Department for International Development (DFID).

Dr Paul Beckett is Consultant Respiratory Physician at University Hospitals of Derby and Burton. He has been a clinical lead for the National Lung Cancer Audit for more than 10 years, and through this has published a number of research papers on lung cancer epidemiology. He has served as a member of the British Thoracic Oncology Group steering group and as chair of the British Thoracic Society Lung Cancer and Mesothelioma Specialist Advisory Group. He is a member of the Royal College of Physicians Quality Improvement Faculty, combining both theoretical and practical experience in delivering service improvement. He was recently appointed as one of the clinical leads for the Getting It Right First Time (GIRFT) lung cancer workstream.

Professor Matthew Brookes is a Consultant Clinical Gastroenterologist at the Royal Wolverhampton NHS Trust. He is involved in research which has been funded by CORE, BACR, RfPB, Health foundation, HTA and Crohn’s and Colitis UK. He has published over 70 peer-reviewed papers. He is the clinical speciality research lead for Gastroenterology within the West Midlands network and is a member of the research committee at the RCP. He is the deputy chair of the national speciality group and also the position of deputy clinical director for the NiHR West Midlands CRN.

Mark Caulfield graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital where he developed a research programme in molecular genetics of hypertension which has discovered over 1000 gene loci for blood pressure. He was appointed Director of the William Harvey Research Institute in 2002 and was elected a Fellow of the Academy of Medical Sciences in 2008. Between 2010 and 2015 he co-led the merger of three hospitals in North London to create the new £400 million Barts Heart Centre which provides 80,000 cardiovascular patient episodes. He has won the Lily Prize of the British Pharmacology Society, the Bjorn Folkow Award of the European Society of Hypertension 2016 and the Franz Volhard Award of the International Society of Hypertension in 2018. In 2013 he became an NIHR Senior Investigator and was appointed as the Chief Scientist for Genomics England (100,000 Genomes Project).  He was appointed Interim Chief Executive Officer for Genomics England from January to September 2019.  Sir Mark was awarded a Knighthood in the June 2019 Queen’s Birthday Honours List for services to the 100,000 Genomes Project.

Simon’s ambition is to improve outcomes for frail older people by embedding evidence based medicine into clinical practice (‘campus to clinic’ translational research). His research addresses different models of care for frail older people, assessing feasibility as well as clinical and cost-effectiveness. His educational activities take an interdisciplinary perspective on developing and teaching knowledge locally (frailty services), nationally (BGS) and internationally (EUGMS & EAMA). Implementation of research findings into clinical practice is key, and best exemplified by work on the Silver Book and the Acute Frailty Network and Specialised Clinical Frailty Network.

Consultant Cardiologist for 20 years – trained in adult coronary and valve intervention. Been BCIS Chair of Clinical Standards Group andVice President Clinical Standards BCS Widely published in interventional coronary trials with a particular focus on elderly patients and calcific coronary disease. The interaction between the heart and the mind is complex. The lecture will explore the impact of one over the other, and will show that under certain circumstances the mind can dominate the heart, yet at other times the heart can stranglehold the mind.

Professor Kevin Fenton is the Strategic Director of Place and Wellbeing and Director of Public Health at the London Borough of Southwark. In this role, which incorporates the statutory functions of the Director for Public Health, he works across the entire Council to champion and promote health, wellbeing, sustainability and equity in all policies and programmes. Key priorities include social regeneration, developing and supporting sustainable, high-quality and integrated health and social care systems, and improving health and reducing inequalities for all of Southwark’s residents. Professor Fenton is on secondment to Southwark Council from Public Health England (PHE), where he was the National Director for Health and Wellbeing leading PHE’s national prevention programmes including screening for cancer and other conditions, Health Checks, public mental health, sexual and reproductive health, and a range of wellbeing programmes for infants, youth, adults and older adults. He also led PHE’s health equity portfolio with a range of programmes and activities focused on addressing the social determinants of health and promoting place-based approaches to health improvement. Professor Fenton was previously the director of the National Centre for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centres for Disease Control and Prevention (CDC), a position he held for seven years from November 2005. He also served as chief of CDC’s National Syphilis Elimination Effort and has worked in research, epidemiology, and the prevention of HIV and other STDs since 1995. Previously he was the director of the HIV and STI Department at the United Kingdom’s Health Protection Agency. He attended medical school in Jamaica, obtained his master’s in public health at the London School of Hygiene and Tropical Medicine, and PhD in Infectious Disease Epidemiology at the University College London. He has authored or co-authored more than 250 peer-reviewed scientific articles and policy reports.

James Ferguson is a transplant hepatologist based at the Queen Elizabeth Hospital in Birmingham. He is the clinical lead on the IQILS (Improving quality in liver services) project and was a co-author of the recent lancet commission on liver disease in the UK

Professor Neil Gittoes leads the metabolic bone diseases unit in Birmingham and is Head of the Centre of Endocrinology, Diabetes and Metabolism. He leads a number of national work streams and is Chair of the Board of Trustees, Royal Osteoporosis Society. He was Clinical Lead for the NICE Guideline on Primary Hyperparathyroidism. Neil is Chairman of the Clinical Reference Group for Specialised Endocrinology, NHSE/I. His clinical and research interests focus on disorders of calcium homeostasis and rare causes of fracture susceptibility.

Fiona Godlee is the Editor in Chief of The BMJ. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. She has written and lectured on a broad range of issues, including health and the environment, the ethics of academic publishing, evidence based medicine, access to clinical trial data, research integrity, open access publishing, patient partnership, conflict of interest, and overdiagnosis and overtreatment. After joining The BMJ as an assistant  editor in 1990, she moved in 2000 to help establish the open access publisher BioMedCentral as its founding Editorial Director for Medicine. In 2003 she returned to BMJ to lead its Knowledge division and was appointed Editor in Chief of The BMJ in March 2005. Fiona is honorary professor at the Netherlands School for Primary Care Research (CaRe), honorary fellow of the Royal College of General Practitioners, a senior visiting fellow at the Institute of Public Health at the University of Cambridge, honorary fellow of the Faculty of Public Health and a by-fellow of King’s College Cambridge. She is on the advisory or executive boards of the Health Improvement Studies (THIS) Institute (thisinstitute.cam.ac.uk), Alltrials (alltrials.net), the Peer Review Congress (peerreviewcongress.org), the International Forum for Quality and Safety and Healthcare (internationalforum.bmj.com), Evidence Live (evidencelive.org), Preventing Overdiagnosis (preventingoverdiagnosis.net), the UK Health Alliance on Climate Change (ukhealthalliance.org) and the Climate and Health Council. She was a Harkness Fellow (1994-5), President of the World Association of Medical Editors (WAME) (1998-2000), Chair of the Committee on Publication Ethics (COPE) (2003-5), and PPA Editor of the Year (2014). Fiona is co-editor of Peer Review in Health Sciences.  She lives in Cambridge with her husband and two children.

Professional career

I am a Consultant Dermatologist with a special interest in Allergy. I lead the specialist Urticaria and Mastocytosis clinics at St John’s Institute of Dermatology, Guy’s and St Thomas NHS Trust, London. Prior to this, I was a Consultant Dermatologist at the Norfolk and Norwich University Hospital for 25 years. My interest in Urticaria started in1985 when I investigated the clinical characteristics, immunology and histopathology of the autologous serum skin test in chronic idiopathic urticaria leading to the identification of functional IgG autoantibodies against IgE and the FceRI with follow on clinical trials of plasmapheresis and ciclosporin.

Education and academic career

I have presented at many national and international meetings in the field of cutaneous Allergy. I was editor of Clinical and Experimental Dermatology from 2004 to 2007 and am currently co-Editor in Chief of Clinical and Translational Allergy. I have sat on Advisory Boards for the Department of Health, Medicines Healthcare Regulatory Authority and the European Medicines Agency.

Activities and participation in scientific societies

I am a member of the European Academy of Allergy and Clinical Immunology, the European Academy of Dermatology and Venereology, the British Society of Allergy and Clinical Immunology and the British Association of Dermatology. I was chair of the Dermatology section and Executive Board member of the European Academy of Dermatology from 2011 to 2013. I was President of the Dermatology section of the Royal Society of Medicine in 2013 and President of the St John’s Dermatological Society in 2017. I am an honorary member of the Finnish and French Dermatological Societies and The Australasian Mastocytosis Society. I have published more than160 papers in peer-reviewed journals and written or co-authored 33 textbook chapters. I am co-editor of the monograph Urticaria and angioedema, Springer and co-author of 12 guidelines and 13 position papers.

Salman graduated from Guy’s, King’s and St.Thomas’ Medical school with an intercalated BSc in Neuroscience. He undertook medical training at Barts and The London, followed by one year as an acute medical registrar. He began neurology training in 2008 in London and undertook a PhD at the Institute of Neurology Queen Square. He was appointed as UCL Teaching fellow in 2018 at the Education Unit Queen Square. Here he is developing distance based learning programmes in neurology. He is currently in the second year of a clinical fellowship at UCLH attempting to establish an Acute Neurology service at UCLH & NHNN. Far more important than any of this, he became a 6 time champion of Europe in Madrid in 2019.

Dr Vijay Hajela FRCP Consultant in Rheumatology and Acute Medicine Brighton and Sussex University Hospitals NHS Trust.Vijay Hajela has been involved in the organisation and delivery of medical education for many years. As a Consultant in Lewisham for 10 years he became Director of Medical Education.  He has been an examiner for the Royal College of Physicians PACES exam since 2005. In 2007 he was the National Association of Clinical Tutors Travelling Fellow to the US looking into the subject of handover between medical teams. In 2010 he joined BSUH where he has been Clinical Lead for Rheumatology, Deputy and Acting Chief of Medicine. His clinical interests include fever syndromes, connective tissue disease and vasculitis.

Dr. Anita Hill is a Consultant Haematologist for Leeds Teaching Hospitals NHS Trust, UK and Honorary Clinical Associate Professor for the University of Leeds. She is also Head of the National PNH Service, UK. In addition, Dr Hill specialises in aplastic anaemia and haemolytic anaemias, seeing patients both in Leeds as well as throughout the UK in many Outreach Clinics. She led on the first guidelines for the management of primary and secondary Autoimmune Haemolytic Anaemia in 2016 and contributed to the guideline for Aplastic Anaemia, both for the British Society of Haematology. Prior to these posts, Dr. Hill worked as a Consultant Haematologist for Bradford Teaching Hospitals NHS Foundation Trust, where she was the Lead for clinical trials and research. Dr. Hill received her medical degree with distinctions and honours from the University of Sheffield, UK. She did her post-graduate training at Sheffield Teaching Hospitals NHS Trust, St George’s Hospital, London and the Royal Marsden Hospital, London. Dr. Hill went on to specialise in haematology at Leeds Teaching Hospitals NHS Trust. She was awarded her PhD for exploring the role of complement and nitric oxide in the pathophysiology of PNH and other haemolytic anaemias. Dr Hill is active in many clinical trials furthering therapies for PNH, aplastic anaemia and autoimmune haemolytic anaemias and is the Chief Investigator of many international trials for PNH. Dr. Hill has published extensively in peer-reviewed journals and is actively involved in the PNH Global Registry. Furthermore, Dr. Hill is a member of the Royal College of Pathologists, the British Society of Haematology and the International PNH Interest Group. She has served as an elected member of the North of England Regional Council, Royal College of Pathologists and is a committee member for the UK Red Cell Specialist Interest Group.

Dr Binita Kane is a Consultant Respiratory Physician at Manchester University Foundation Trust (MFT). She has an interest in airways disease, quality improvement (QI) and leadership. She is currently the lead for integrated respiratory care at MFT, the Health Innovation Manchester GM Respiratory programme and the North West Severe Asthma Network. She is a member of the PCRS Service Delivery Committee, RCP QI Faculty, the National Asthma and COPD Audit Programme (NACAP) Board and NHSE Long Term Plan Respiratory Workstreams.

Dr Lester is a Haematology Consultant at University Hospitals Birmingham, Queen Elizabeth and Birmingham Women’s Hospital and Honorary Senior Clinical Lecturer, Institute of Cardiovascular Sciences, University of Birmingham. Clinical and research interests include thrombosis and haemostasis, obstetric and immuno-haematology.  Lecturer at the National Centre for Anticoagulant Training and has received two thrombus innovation awards. Member of British Society for Haematology Haemostasis and Thrombosis guidelines task force, NEQAS blood coagulation steering committee and co-chair of the UKHCDO laboratory working group. Fan of mischief and realistic medicine and foe of over-investigation and referendums.

Dagan Lonsdale is a senior lecturer in clinical pharmacology and therapeutics at St George’s, University of London and consultant physician-intensivist at St George’s University Hospitals NHS Foundation Trust. His research and education interests are in the improved prescription and use of medicines. His PhD thesis examined the pharmacokinetics of antimicrobials in critical illness and produced the first whole-life pharmacokinetic models of beta-lactams. He lectures in clinical pharmacology and statistics to undergraduate MBBS and BSc students and postgraduate doctors in training.

Danny McAuley is a Consultant and Professor in Intensive Care Medicine at the Regional Intensive Care Unit at the Royal Victoria Hospital and Queen’s University of Belfast. He undertook his training in Belfast, Birmingham, London and San Francisco. He is Programme Director for the MRC/NIHR Efficacy and Mechanism Evaluation (EME) programme and Co-Director of Research for the UK Intensive Care Society. He has several research interests including Acute Respiratory Distress Syndrome, extracorporeal CO2 removal and clinical trials.

Lawrence Mudford has had a 38-year healthcare career working as a dentist, dental educator and Regulator within both primary and secondary care. This has included serving on the board of the Faculty of General Dental Practice and as a member of the General Dental Council.

“The NHS Long Term Plan recognises the need for an integrated healthcare approach focused on a “shared responsibility”. To see this actioned and integrated would be my wish for the NHS, as it allows the patient’s journey to be central and at the heart of personalisation of care.”

Catherine Nelson-Piercy is a Consultant Obstetric Physician at Guy’s and St. Thomas’ Hospitals Trust and Queen Charlotte’s and Chelsea Hospital in London. In 2010 she was awarded the title of Professor of Obstetric Medicine at King’s College London. Her undergraduate studies were at King’s College, Cambridge University and St Bartholomew’s Hospital. She trained as a physician, and was taught Obstetric Medicine by Professor Michael de Swiet. Professor Nelson-Piercy is past President of the International Society of Obstetric Medicine (ISOM). She is founding co-editor in chief of the journal ‘Obstetric Medicine: the medicine of pregnancy.’  Professor Nelson-Piercy has been involved in the development of several evidence-based National Guidelines notably for “Contraception in Women with Heart Disease”, BTS / SIGN “Asthma in Pregnancy” and RCOG Green top guidelines on “Reducing the risk of thromboembolism during pregnancy, birth & the puerperium” and ‘Management of nausea vomiting of pregnancy and hyperemesis gravidarum”. She has over 200 publications and has edited five books and written the successful Handbook of Obstetric Medicine, now in its fifth edition. She is also one of the central physician assessors for the UK Confidential maternal deaths enquiry.

Donal is the Registrar at the RCP responsible for professional leadership, membership matters, global engagement and supporting the President in system wide engagement to improve patient care and outcomes. Donal trained in Renal Medicine and Internal Medicine in Manchester, Paris and Edinburgh. He is a Renal Physician at Salford Royal Hospital and Professor of Renal Medicine at the University of Manchester with research interests in healthcare systems, quality improvement and innovation in education and service delivery. Previous roles have included inaugural President of the multi-professional British Renal Society, National Director for Kidney Care in England and President of the Renal Association. Donal is chair of Kidney Care UK, a charity supporting patients and carers. He was awarded OBE in 2018 for services to kidney patients.

Marco Proietti is currently Assistant Professor of Geriatric at University of Milan.  He is Geriatric consultant at the Geriatric Unit at Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan.  He is Honorary Research Fellow at ‘Liverpool Centre for Cardiovascular Science’, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom. His research interests are in the field of epidemiology, clinical management and pharmacological treatment of cardiovascular diseases, in particular atrial fibrillation. In the last years he has gained significant experience in the study of clinical factors and concomitant diseases associated with atrial fibrillation. In particular, he studied the management of oral anticoagulant therapy and the relationship between atrial fibrillation and adverse clinical events (thromboembolic, bleeding, cardiovascular events, mortality). He is Fellow of the European Society of Cardiology (FESC) and Fellow of the European Heart Rhythm Association (FEHRA).  He is reviewer for several international journals (>140 verified peer reviews certified in Publons https://publons.com/a/1553553). He is Editorial Board member for Archives of Medical Sciences, Open Heart, TH Open, Thrombosis & Haemostasis. He is Section Editor/Managing Editor for Archives of Medical Sciences and Thrombosis & Haemostasis. He is author of more than 100 peer-reviewed original articles, with more than 1000 citations and an H-index of 19 (Scopus).

Tony Redmond qualified in Medicine from the University of Manchester where he completed his specialist training in Emergency Medicine. In 1995 he was appointed Professor of Emergency Medicine at the University of Keele and where is now Emeritus Professor of Emergency Medicine. In 1994 he established UK-Med www.uk-med.org, an NGO that provides international emergency humanitarian medical assistance to sudden onset disasters, outbreaks and conflicts, and which hosts the UK International Emergency Trauma, Medical and Public Health Registers. He is now Chair of the Board of Trustees. In 2008 he co-founded, the Humanitarian and Conflict Response Institute (HCRI) (www.hcri.ac.uk) at the University of Manchester where he is now Professor Emeritus International Emergency Medicine. He established the WHO Collaborating Centre for Emergency Medical Teams and Emergency Capacity Building at HCRI, and is a member of the WHO EMT Mentorship and Verification Team. He is Visiting Professor of Disaster Medicine at the University of Sichuan, China, and the Immediate Past President of the World Association for Disaster and Emergency Medicine.

Ian Roberts is Professor of Epidemiology at the London School of Hygiene & Tropical Medicine. He trained as a paediatrician in the UK and then in epidemiology at the University of Auckland, New Zealand and McGill University, Canada. He is a clinical academic who works collaboratively with health professionals world-wide to conduct large multi-centre clinical trials aimed at improving patient outcomes in life threatening emergencies. He works with others to build global research partnerships to answer questions together that could not be answered by anyone working alone. He has played lead roles in several large trials including the CRASH trials and the Woman trial.

Dr Gareth Roberts is a consultant nephrologist and associate medical director at Aneurin Bevan University Health Board. He is clinical lead for the value based health care programme. He is deputy lead of the Welsh Renal Clinical Network and a research active consultant whose PhD focussed on inflammation and immunity. He is currently chief investigator of a national study looking at the socio-demographic factors that influence shared decision making in patients with advanced kidney failure

Professor Sebastian (Seb) is the lead clinician at the IBD unit in Hull University teaching Hospitals, Hull. He leads an integrated IBD Unit (IBD HULL) of clinical and research staff which prides in personalised care models for IBD patients. IBD Hull has gained recognition as one of the most research active IBD units in the UK and leads and collaborates in a number of multicentre national and international IBD studies. The current research areas are in acute severe colitis, perianal Crohn`s disease, Inception cohort studies and pharmaco-epidemiology.  He has over 100 peer reviewed publications focussing on IBD (H- index 28, I- index 45).  He has also been co-author for a number of European Colitis and Crohn`s Organisation (ECCO) guidelines and workshops in various aspects of IBD.  Seb is currently in the CLINICOM and CONFER Task Force committees of ECCO, Co-leads the Y&H NIHR LCRN gastroenterology speciality and current member of IBD CRG and the IBD section, and past chair of the Adolescent Section of British Society of Gastroenterology.

Dr Sivasubramaniam is a consultant anaesthetist at Sandwell and West Birmingham Hospitals NHS Trust and local lead for perioperative medicine and my special areas of interest include, Perioperative care, Hip Fracture care, Trauma anaesthesia, anaesthesia for colorectal surgery, pre-assessment clinics and perioperative medicine.  He reorganised trauma anaesthetic services to provide a 7-day consultant led perioperative care. This includes the concept of “trauma anaesthetist of the week” and an additional ward based “perioperative anaesthetist”. A core group of senior anaesthetists provide standardised care to these patients, seven days a week, not only within the operating theatre but also during their perioperative period, from admission to 48 hours after surgery.  This has led to several demonstrable improvements in perioperative care for hip fracture patients. Our novel model of the dedicated ‘perioperative anaesthetist’ at Sandwell and West Birmingham Hospitals, led us to win the BMJ Awards 2019 for ‘Anaesthesia and Perioperative Medicine Team of the year’.

Faculty of Health and Well-being, University of Central Lancashire: Professor of Stroke and Older People’s Care, Director of Research and Innovation; Director of Lancashire Clinical Trials Unit and Director of Lancashire research Institute For global health and well-being (LIFE). She is the only nursing professor of stroke care in the UK and contributes to stroke service development at a local, national and international level. Caroline leads a multidisciplinary team of researchers with a large portfolio of clinically relevant research which spans five areas in stroke and older peoples’ care: prevention and pre-hospital care, education and workforce development, acute care, rehabilitation and long-term care. Caroline is deeply committed to the implementation of healthcare improvement which is reflected in her recent appointment of Implementation Lead for NIHR Applied Research Collaboration North West Coast (NIHR ARC NWC). Caroline’s work was recognised with the award of the DBE for Services to Nursing and Older People’s Care in 2017 and is honoured to be current Chair of UK Stroke Forum.  Caroline received National Institute for Health Research (NIHR) Senior Investigator Award in 2009 and 2016, and acts as NIHR Academic Training Advocate for Nursing clinical academic careers.

Dr Lisa Willcocks qualified from Oxford University in 1998, and was awarded a PhD from the University of Cambridge in 2009. She has been a Consultant Nephrologist at Cambridge University Hospital since 2010. She is part of the world renowned Cambridge Vasculitis and Lupus Service, which has led several multinational RCTs in ANCA vasculitis. She also has a specialist interest in Primary Glomerulonephritis, and is Chief Investigator for Multi centre trials in MCD/FSGS and IgA Nephropathy.

Dr Emma Wilmot MB ChB BSc (hons) PhD FRCP Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust Honorary (consultant) Assistant Professor, University of Nottingham Emma Wilmot is a Consultant Diabetologist at University Hospitals of Derby and Burton NHS Foundation Trust. Her specialist interests include Type 1 diabetes, insulin pump therapy and diabetes technology, young adults with diabetes and antenatal diabetes care. She was awarded the University of Leicester medal for excellent PhD performance in 2013 for her PhD “Type 2 diabetes in younger adults” and was appointed as a Honorary (consultant) Assistant Professor at the University of Nottingham in 2018. She is principal investigator on several diabetes research trials. She is founder of the ABCD Diabetes Technology Network UK. As chair she previously led the delivery of educational events for multidisciplinary diabetes teams and the development of national insulin pump ‘best practice’ guides, in addition to online modules for people living with diabetes. Emma is an elected Association of British Clinical Diabetologists (ABCD) committee member and DAFNE structured education executive board member. She is a member of the National Diabetes Audit Insulin Pump Expert Reference Group and has also been involved in the #languagematters movement.

After obtaining dental ( Kings College London), medical ( University of Cambridge ) degrees and specialist training in oral medicine Professor Joanna Zakrzewska went on to specialize in orofacial pain. Awarded a personal chair in facial pain by the University of London she is also one of the few non anaesthetic Fellows of the Faculty of  Pain Medicine.  Between 2007- 2015 she set up the largest award winning UK multi-disciplinary facial pain service at UCLH NHS Foundation Trust. She has written four books, contributed to 20 chapters and written over 130 peer reviewed papers and has been rated as the top expert in trigeminal neuralgia in the world.